These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 20501787)
1. New US law applies 'sunshine' to physician payments and gifts from drug, device industries. Woodward C CMAJ; 2010 Jul; 182(10):E467-8. PubMed ID: 20501787 [No Abstract] [Full Text] [Related]
2. Doctors face compulsory system to declare gifts and hospitality from drug companies. O'Dowd A BMJ; 2015 Aug; 351():h4617. PubMed ID: 26311722 [No Abstract] [Full Text] [Related]
4. Two years of sunshine: has openness about payments reduced industry influence in healthcare? Lenzer J BMJ; 2016 Aug; 354():i4608. PubMed ID: 27562781 [No Abstract] [Full Text] [Related]
5. Brightening up: the effect of the Physician Payment Sunshine Act on existing regulation of pharmaceutical marketing. Gorlach I; Pham-Kanter G J Law Med Ethics; 2013; 41(1):315-22. PubMed ID: 23581674 [TBL] [Abstract][Full Text] [Related]
6. CME shelter. Sunshine Act waiver for med ed payments may prompt marketing shift for product makers. Lee J Mod Healthc; 2014 Jun; 44(26):16-9. PubMed ID: 25134407 [No Abstract] [Full Text] [Related]
7. Drug companies will have to report all payments to US doctors from March 2014. Roehr B BMJ; 2013 Feb; 346():f826. PubMed ID: 23393117 [No Abstract] [Full Text] [Related]
8. Sunlight as disinfectant--new rules on disclosure of industry payments to physicians. Rosenthal MB; Mello MM N Engl J Med; 2013 May; 368(22):2052-4. PubMed ID: 23718162 [No Abstract] [Full Text] [Related]
9. Letting the sunshine in: shining a new light on physician-industry relationships. Bruguera CM; Hirsch JA J Neurointerv Surg; 2010 Mar; 2(1):80-2. PubMed ID: 21990565 [TBL] [Abstract][Full Text] [Related]
10. Already feeling the heat: Docs rethinking payments as Sunshine Act looms. Lee J Mod Healthc; 2013 Jul; 43(26):12-3. PubMed ID: 23878901 [No Abstract] [Full Text] [Related]
11. Pharmaceuticals and medical devices: business practices. Steiner DJ Issue Brief Health Policy Track Serv; 2013 Dec; ():1-36. PubMed ID: 24482889 [No Abstract] [Full Text] [Related]
12. Big bad pharma: an ethical analysis of physician-directed and consumer-directed marketing tactics. Connors AL Albany Law Rev; 2009 Sep; 73(1):243-82. PubMed ID: 20235401 [No Abstract] [Full Text] [Related]
13. Sunshine laws and the pharmaceutical industry. Brennan TA; Mello MM JAMA; 2007 Mar; 297(11):1255-7. PubMed ID: 17374820 [No Abstract] [Full Text] [Related]
14. The Sunshine Act: how to avoid getting burned. Hurd P Fam Pract Manag; 2013; 20(5):8-10. PubMed ID: 24134101 [No Abstract] [Full Text] [Related]
15. Can India stop drug companies giving gifts to doctors? Mukherjee R BMJ; 2013 Apr; 346():f2635. PubMed ID: 23628750 [No Abstract] [Full Text] [Related]
16. French "sunshine act" sheds little light on drug industry's payments to doctors, say critics. Benkimoun P BMJ; 2013 Jun; 346():f3762. PubMed ID: 23757751 [No Abstract] [Full Text] [Related]
17. The Sunshine Act--effects on physicians. Agrawal S; Brennan N; Budetti P N Engl J Med; 2013 May; 368(22):2054-7. PubMed ID: 23718163 [No Abstract] [Full Text] [Related]
18. Shining a light on the Sunshine Act. Peck AA J Med Assoc Ga; 2013; 102(2):28. PubMed ID: 24006732 [No Abstract] [Full Text] [Related]
19. Transparency of industry payments needed in clinical practice guidelines. Vassar M; Bibens M; Wayant C BMJ Evid Based Med; 2019 Feb; 24(1):8-9. PubMed ID: 30042209 [No Abstract] [Full Text] [Related]
20. An Analysis of the Open Payment Database in Neurotology. Ziai K; Sahyouni R; Moshtaghi O; Vu K; Goshtasbi K; Ghavami Y; Lee L; Lin HW; Djalilian HR Otolaryngol Head Neck Surg; 2018 Feb; 158(2):319-322. PubMed ID: 29389305 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]